News
-
-
-
PRESS RELEASE
Beta Bionics Announces the Nationwide Launch of the iLet Bionic Pancreas With Dexcom G7 CGM System
Beta Bionics, Inc. will launch the iLet Bionic Pancreas with Dexcom G7 CGM System on Dec. 18, 2023, allowing users to update without additional hardware costs. The system streamlines diabetes management with quick and easy integration and offers choice to users. Dexcom G7 is the fastest and most accurate CGM available -
-
Aston Bay Holdings Closes $2,137,860 Second Tranche of Non-Brokered Private Placement for $3,517,860 Total to Date
-
Apex Critical Metals Corp. Signs Earn-In Agreement with Discovery Lithium & DG Resource Management
-
Discovery Lithium Announces Earn-In Option on Quebec Property Portfolio
-
Zimtu Capital Announces Agreement with Apex Critical Metals
-
Alinia AI Raises $2.4M in Pre-Seed Funding to Enable Safe & Controlled Deployment of Generative AI
-
Patrimonium Swiss Real Estate Fund: stable results in a difficult environment
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
Eighteenth Annual General Meeting of Delticom AG
-
Annual General Meeting of CANCOM SE elects Supervisory Board and approves dividend of € 1.00
-
PNE AG successfully sells its US division to Lotus Infrastructure Partners
-
Shareholders’ Meeting and Board of Directors’ meeting on June 6, 2024
-
Disclosure of voting rights - 06.06.2024
-
Eurazeo announces the signing by Grape Hospitality of an exclusivity agreement for the sale of 23 hotels
-
Safran: Update on proposed acquisition of Collins Aerospace’s actuation and flight control business
-
Aéroports de Paris SA - Voting rights as of 31 May 2024